Interpace Diagnostics AccuCea Insights

Interpace Diagnostics has launched AccuCea Insights, a diagnostic testing service that aids in diagnosing and treating pancreatic cancer. The service provides physicians with additional information on how to compare diagnostic test results to those of other patients through Interpace's database of over 15,000 patients, the company said. Once reports are delivered to ordering physicians, they have an opportunity to speak with one of the company's molecular pathologists to discuss the potential benefits of conducting a full, molecular pathology review.